what is oral semaglutide Approved to Reduce the Risk of Cardiovascular Events Oral Semaglutide Show Promise as

Repartitioning drugs, such as growth hormone, anabolic steroids and B2-agonists (e.g., salbutamol), stimulate skeletal muscle hypertrophy and reduce fat mass

The CMS BALANCE model may expand Medicare/Medicaid GLP-1 access starting mid-2026

Cancer treatment is a journey that involves not only the physical but also the emotional and psychological aspects of health

Capturing the Opportunity: The convergence of the booming GLP-1 market and the growing demand for behavior change solutions creates a once-in-a-lifetime business opportunity for digital health companies that offer behavioral change support

Discussion Observations IMSs are rare, with only 12 cases previously reported